Medicus Pharma (Medicus Pharma) Short-Term Debt : $0.00 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Medicus Pharma Short-Term Debt?

Medicus Pharma's Short-Term Debt for the quarter that ended in Dec. 2023 was $0.00 Mil.

Medicus Pharma's quarterly Short-Term Debt declined from Jun. 2023 ($2.35 Mil) to Sep. 2023 ($0.00 Mil) but then stayed the same from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($0.00 Mil).

Medicus Pharma's annual Short-Term Debt increased from Dec. 2021 ($0.67 Mil) to Dec. 2022 ($1.53 Mil) but then declined from Dec. 2022 ($1.53 Mil) to Dec. 2023 ($0.00 Mil).

Medicus Pharma Short-Term Debt Historical Data

The historical data trend for Medicus Pharma's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicus Pharma Short-Term Debt Chart

Medicus Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Short-Term Debt

0.67

1.53

Medicus Pharma Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Short-Term Debt	Get a 7-Day Free Trial				1.53	1.72	2.35	-	-

Medicus Pharma Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Medicus Pharma Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Medicus Pharma's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicus Pharma (Medicus Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicus Pharma Ltd (OTCPK:MDPLF) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

MDCX:Canada

Address

100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4

Website

http://www.medicuspharma.com

Medicus Pharma Ltd will carry on the business of pharmaceutical drug development focused initially on SkinJect. The objective of SkinJect is developing and commercializing novel microneedle arrays for the purpose of treating certain skin cancers, initially basal cell carcinoma.

Medicus Pharma (Medicus Pharma) Headlines

From GuruFocus

Medicus Pharma Opens the Market

By PRNewswire • 10-26-2023